ESR1 and breast cancer: For instance, crosstalk between classical (ER and PR) and nonclassical (PGRMC1) signaling mechanisms exists in ER+ breast cancer cells, enhancing the growth of ER+/PR+/PGRMC1-overexpressing tumors [46].